3 4 5-Trimethoxycinnamic Acid CAS 90-50-6

1. Serves 3 4 5-Trimethoxycinnamic acid CAS 90-50-6 as a core intermediate for synthesizing cardiovascular drugs like cinepazide and anti - convulsant pharmaceuticals, leveraging its phenylpropanoid structure for targeted receptor binding.

2. Acts 3 4 5-Trimethoxycinnamic acid as a surface modifier to boost adhesion between glass fibers, siliceous fillers and resins (epoxy, phenolic) in composite materials, enhancing mechanical and electrical performance.

3. Functions as a research tool for studying GABAergic and serotonergic receptor pathways, aiding the development of sedative, anti - seizure and anti - stress drug candidates.

Store 3,4,5-trimethoxycinnamic acid (CAS 90-50-6, trans - dominant) in sealed amber glass containers at 15–25°C in a cool, dry, well - ventilated area, away from direct sunlight, heat and strong oxidants (melting point 182–185°C, non - flammable solid). Isolate from strong bases and reducing agents to avoid ester - hydrolysis and preserve chemical stability. Wear nitrile gloves, safety goggles and lab coats during handling; avoid inhalation, skin/eye contact and ingestion to prevent mild irritation. Reseal tightly after use; dispose of waste per local hazardous chemical and environmental regulations.

3,4,5-Trimethoxycinnamic acid is a pharmaceutical intermediate, composite modifier and research compound, not for direct human ingestion in pure form; unregulated intake may cause digestive discomfort and pose unknown health risks.

In regulated applications, 3 4 5-Trimethoxycinnamic acid CAS 90-50-6 enables the synthesis of therapeutic drugs for heart - blood vessel conditions and neurological disorders, improves composite material durability, and supports neuroscience research for novel treatment development.